When I read that experts had officially renamed PCOS to polyendocrine metabolic ovarian syndrome, my first reaction was not surprise. It was relief. After years of practicing medicine and six years of treating my own PCOS, someone had finally written down what my body had been trying to tell me the whole time.
Six years ago I was building my own practice from the ground up while quietly falling apart inside. My cycles were irregular. I was seeing a gynecologist, taking the medications I was told to take, doing everything by the book. Nothing worked. Every month that passed without a pregnancy felt like another month of failing a test I did not understand.
What I had overlooked was the question I was asking. Instead of asking why my body was struggling in the first place, I had been focused on how to fix my ovaries.
According to the World Health Organization, PCOS affects roughly 1 in 10 women of reproductive age worldwide, yet up to 70 percent of cases go undiagnosed. For decades the name pointed everyone toward a single organ. The word “polycystic” made the condition sound structural, something you could see on an ultrasound and treat accordingly. The real picture was far more complicated than that.
Real physician voices, twice a week
Free, and one click to unsubscribe.
The new name comes from a global consensus paper published in the Lancet. It reframes this as a multi-system condition involving the endocrine system, metabolism, reproductive health, mental health, and the skin. That list is not a footnote. It is the actual diagnosis I had.
I remember the evening I stopped following the conventional protocol and started testing differently. I ran a full hormone panel, not just the standard reproductive markers. I did a four-point cortisol curve to see how my stress response was functioning across a full day, and I tested my micronutrient status including magnesium, vitamin D, zinc, and inositol, all of which are commonly depleted in women with this condition and rarely checked in a standard workup.
The results were not subtle. My cortisol was dysregulated, my nutrients were depleted, and my body was running in a state of chronic physiological stress. I had been treating a metabolic and endocrine condition as if it were a plumbing issue.
This is the trap the old name set for patients and clinicians alike. When the name says “ovary,” the treatment targets the ovary. Medications like metformin and oral contraceptives address specific downstream symptoms, but they are not designed to ask why those symptoms are happening. There is a meaningful difference between managing a condition and understanding it.
Once I shifted my focus, my body responded. I reduced my stress load deliberately, not as a vague lifestyle suggestion but as a clinical intervention, because cortisol directly suppresses the hormones involved in ovulation and implantation. Research consistently shows that women with PCOS have significantly higher baseline cortisol than women without the condition, which means the stress axis is part of the biology, not a side issue.
I corrected the specific nutrient deficiencies that were quietly undermining my hormone production. Within four months my cycles regulated. A few months later, I was pregnant.
I am not sharing this to suggest my path is a formula for every woman. I am sharing it because the emotional weight of this condition is real, and the standard approach often leaves women feeling like they are failing their own bodies. I felt that. I know what it is like to track every symptom, do everything right by conventional standards, and still come up empty.
The rename from PCOS to PMOS matters because language shapes treatment. When the medical community formally acknowledges this is an endocrine and metabolic condition first, it opens the door to a different kind of workup. It creates room to ask about cortisol patterns, insulin sensitivity, nutrient status, and the psychological burden that the new definition explicitly names as part of the condition itself.
This is the deeper lesson I think the rename forces all of us to sit with, and it reaches well beyond PMOS. Symptom management is not the same as healing. When we reach straight for a prescription without asking what the body is actually responding to, we are not treating the condition. We are silencing the alarm and walking away from the fire.
Symptoms are information. Irregular cycles, skin changes, mood shifts, fatigue, none of these are random. They are the body pointing at something upstream, and the question worth asking is not how to quiet the signal but what the signal is trying to say.
A name change will not automatically change how every physician approaches this condition. But it is a formal acknowledgment, backed by a global consensus, that the picture is bigger than the old name ever let on. For women who have spent years being told their labs are normal while their bodies were clearly telling them otherwise, that acknowledgment is long overdue.
If you are a woman reading this and feeling guilty about a body that will not cooperate, please hear me. You were never broken. You were being treated for the surface of a condition that lives much deeper, and there is another way to look at it.
If you are a clinician reading this, the rename is not a relabeling exercise. It is permission. Permission to test more broadly, listen more carefully, and lead with the harder first question.
Why is this body doing what it is doing, and what is it actually asking for? That question changed my life. It keeps changing the lives of the women who walk into my clinic every week. The medicine is finally starting to ask it too.
Carrie Lam is a family physician.
